A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia-Reference-Cited by-同舟云学术

A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia

Published:2012-03-20 Issue:1 Volume:12 Page:
ISSN:1471-244X
Container-title:BMC Psychiatry
language:en
Short-container-title:BMC Psychiatry

Author:

DiBonaventura Marco,Gabriel Susan,Dupclay Leon,Gupta Shaloo,Kim Edward

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1186/1471-244X-12-20.pdf

Reference30 articles.

1. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC: Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry. 1996, 53: 1022-1031. 10.1001/archpsyc.1996.01830110060007.

2. Goldner EM, Hsu L, Waraich P, Somers JM: Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Can J Psychiatry. 2002, 47: 833-843.

3. Messias EL, Chen CY, Eaton WW: Epidemiology of schizophrenia: review of findings and myths. Psychiatr Clin North Am. 2007, 30: 323-338. 10.1016/j.psc.2007.04.007.

4. DiBonaventura MD, Panish J, Kenworthy D, Wagner J-S, Dirani R: The association of well-being, productivity and resource use among community-dwelling patients with schizophrenia using atypical antipsychotics. J Pharmaceut Health Serv Res. 2010, 1: 181-187. 10.1111/j.1759-8893.2010.00033.x.

5. Caqueo-Urizar A, Gutierrez-Maldonado J, Miranda-Castillo C: Quality of life in caregivers of patients with schizophrenia: a literature review. Health Qual Life Outcomes. 2009, 7: 84-10.1186/1477-7525-7-84.

Cited by 240 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detailing Healthcare Claims Data Evidence of Extrapyramidal Symptoms in Medicaid Patients with Schizophrenia after Second-Generation Antipsychotic Medication Initiation;Community Mental Health Journal;2024-09-06

2. Updated rationale for the initial antipsychotic selection for patients with schizophrenia;Schizophrenia;2024-09-02

3. Reservoir-type intranasal implants for sustained release of risperidone: A potential alternative for long-term treatment of schizophrenia;Journal of Drug Delivery Science and Technology;2024-09

4. Effects of aripiprazole on prolactin levels and differences in effectiveness in patients with schizophrenia: a post-hoc analysis of the real-world data of a multicenter study;Frontiers in Psychiatry;2024-08-29

5. Real-World Adherence and Discontinuation of Oral Antipsychotics and Associated Factors in a National Sample of US Medicare Beneficiaries with Schizophrenia;ClinicoEconomics and Outcomes Research;2024-08